Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for OTCM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -6.744M
March 31, 2026 -7.191M
December 31, 2025 -23.23M
September 30, 2025 -2.324M
June 30, 2025 -2.41M
March 31, 2025 -5.214M
December 31, 2024 -20.35M
September 30, 2024 -2.179M
June 30, 2024 -2.205M
March 31, 2024 -5.504M
December 31, 2023 -20.26M
September 30, 2023 -2.344M
June 30, 2023 -2.451M
March 31, 2023 -6.039M
December 31, 2022 -20.41M
September 30, 2022 -2.075M
June 30, 2022 -2.46M
March 31, 2022 -5.363M
December 31, 2021 -20.77M
September 30, 2021 -2.201M
June 30, 2021 -1.82M
March 31, 2021 -3.607M
December 31, 2020 -10.45M
September 30, 2020 -1.811M
June 30, 2020 -1.777M
Date Value
March 31, 2020 -5.419M
December 31, 2019 -9.428M
September 30, 2019 -1.896M
June 30, 2019 -1.932M
March 31, 2019 -3.397M
December 31, 2018 -9.347M
September 30, 2018 -1.762M
June 30, 2018 -2.028M
March 31, 2018 -2.745M
December 31, 2017 -8.828M
September 30, 2017 -2.118M
June 30, 2017 -2.062M
March 31, 2017 -3.179M
December 31, 2016 -8.402M
September 30, 2016 -2.248M
June 30, 2016 -1.624M
March 31, 2016 -1.942M
December 31, 2015 -8.45M
September 30, 2015 -1.992M
June 30, 2015 -1.113M
March 31, 2015 -0.959M
December 31, 2014 -6.43M
September 30, 2014 -1.806M
June 30, 2014 -0.726M
March 31, 2014 -0.622M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
CME Group, Inc. -8.091B
Intercontinental Exchange, Inc. -6.012B
MarketAxess Holdings, Inc. -143.61M
Nasdaq, Inc. -583.00M
Cboe Global Markets, Inc. -111.60M